Alcon Sees 12% Q4 Sales Growth to $4.0B on PanOptix and Precision1 Launches
Alcon's Q4 2025 net sales expanded 12% year-over-year to $4.0 billion, propelled by strong uptake of the PanOptix trifocal IOL and Precision1 daily disposable contact lenses. The surgical segment jumped 14% while the vision-care division grew 10%, marking the highest quarterly growth in 24 months.
1. Q4 2025 Financial Performance
Net sales reached $4.0 billion in Q4, up 12% year-over-year (13% constant currency), driven by volume gains across key product categories.
2. Impact of Product Launches
The new PanOptix trifocal IOL and Precision1 daily disposable contact lens saw accelerated adoption and broader distribution, supporting overall revenue growth.
3. Segment Breakdowns
The surgical segment grew 14%, reflecting increased cataract procedures and premium lens mix improvements, while the vision-care division expanded 10% on contact lens replacements and renewals, with notable strength in North America and Europe.